Information Technology Services
Compare Stocks
5 / 10Stock Comparison
CLVT vs VRSK vs MSCI vs TRI vs IHS
Revenue, margins, valuation, and 5-year total return — side by side.
Consulting Services
Financial - Data & Stock Exchanges
Specialty Business Services
Telecommunications Services
CLVT vs VRSK vs MSCI vs TRI vs IHS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Information Technology Services | Consulting Services | Financial - Data & Stock Exchanges | Specialty Business Services | Telecommunications Services |
| Market Cap | $1.78B | $22.89B | $42.83B | $40.72B | $2.76B |
| Revenue (TTM) | $2.45B | $3.10B | $3.13B | $7.66B | $1.58B |
| Net Income (TTM) | $-137M | $910M | $1.32B | $1.53B | $144M |
| Gross Margin | 66.5% | 67.4% | 82.4% | 53.7% | 52.0% |
| Operating Margin | 5.0% | 44.9% | 54.7% | 28.8% | 39.5% |
| Forward P/E | 3.8x | 22.9x | 30.0x | 21.2x | 8.7x |
| Total Debt | $4.48B | $5.04B | $6.31B | $2.12B | $3.51B |
| Cash & Equiv. | $329M | $2.18B | $515M | $511M | $826M |
CLVT vs VRSK vs MSCI vs TRI vs IHS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 21 | May 26 | Return |
|---|---|---|---|
| Clarivate Plc (CLVT) | 100 | 11.9 | -88.1% |
| Verisk Analytics, I… (VRSK) | 100 | 83.1 | -16.9% |
| MSCI Inc. (MSCI) | 100 | 88.5 | -11.5% |
| Thomson Reuters Cor… (TRI) | 100 | 73.6 | -26.4% |
| IHS Holding Limited (IHS) | 100 | 49.0 | -51.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CLVT vs VRSK vs MSCI vs TRI vs IHS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CLVT is the #2 pick in this set and the best alternative if value is your priority.
- Lower P/E (3.8x vs 8.7x)
VRSK is the clearest fit if your priority is growth exposure.
- Rev growth 6.6%, EPS growth -3.3%, 3Y rev CAGR 7.2%
MSCI carries the broadest edge in this set and is the clearest fit for long-term compounding and valuation efficiency.
- 7.2% 10Y total return vs TRI's 155.3%
- PEG 1.77 vs TRI's 2.83
- 9.7% NII/revenue growth vs IHS's -7.6%
- 38.4% margin vs CLVT's -5.6%
TRI ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 7 yrs, beta 0.38, yield 2.5%
- Lower volatility, beta 0.38, Low D/E 17.8%, current ratio 0.64x
- Beta 0.38, yield 2.5%, current ratio 0.64x
- Beta 0.38 vs CLVT's 1.22, lower leverage
IHS is the clearest fit if your priority is momentum.
- +38.6% vs TRI's -50.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.7% NII/revenue growth vs IHS's -7.6% | |
| Value | Lower P/E (3.8x vs 8.7x) | |
| Quality / Margins | 38.4% margin vs CLVT's -5.6% | |
| Stability / Safety | Beta 0.38 vs CLVT's 1.22, lower leverage | |
| Dividends | 1.2% yield, 11-year raise streak, vs TRI's 2.5%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +38.6% vs TRI's -50.0% | |
| Efficiency (ROA) | 24.0% ROA vs CLVT's -1.2%, ROIC 34.9% vs 0.6% |
CLVT vs VRSK vs MSCI vs TRI vs IHS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CLVT vs VRSK vs MSCI vs TRI vs IHS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSCI leads in 2 of 6 categories
CLVT leads 1 • VRSK leads 0 • TRI leads 0 • IHS leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSCI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TRI is the larger business by revenue, generating $7.7B annually — 4.8x IHS's $1.6B. MSCI is the more profitable business, keeping 38.4% of every revenue dollar as net income compared to CLVT's -5.6%. On growth, TRI holds the edge at +8.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.4B | $3.1B | $3.1B | $7.7B | $1.6B |
| EBITDAEarnings before interest/tax | $878M | $1.7B | $2.0B | $3.2B | $991M |
| Net IncomeAfter-tax profit | -$137M | $910M | $1.3B | $1.5B | $144M |
| Free Cash FlowCash after capex | $597M | $1.1B | $1.5B | $1.7B | $599M |
| Gross MarginGross profit ÷ Revenue | +66.5% | +67.4% | +82.4% | +53.7% | +52.0% |
| Operating MarginEBIT ÷ Revenue | +5.0% | +44.9% | +54.7% | +28.8% | +39.5% |
| Net MarginNet income ÷ Revenue | -5.6% | +29.3% | +38.4% | +19.9% | +9.1% |
| FCF MarginFCF ÷ Revenue | +24.4% | +36.3% | +49.4% | +22.7% | +37.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -1.4% | +3.9% | — | +8.3% | -42.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +58.2% | +4.8% | +49.1% | +7.6% | -131.5% |
Valuation Metrics
CLVT leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 19.6x trailing earnings, IHS trades at a 48% valuation discount to MSCI's 37.8x P/E. Adjusting for growth (PEG ratio), MSCI offers better value at 2.23x vs TRI's 3.66x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.8B | $22.9B | $42.8B | $40.7B | $2.8B |
| Enterprise ValueMkt cap + debt − cash | $5.9B | $25.7B | $48.6B | $42.3B | $5.4B |
| Trailing P/EPrice ÷ TTM EPS | -9.28x | 26.92x | 37.81x | 27.46x | 19.61x |
| Forward P/EPrice ÷ next-FY EPS est. | 3.77x | 22.85x | 29.99x | 21.21x | 8.71x |
| PEG RatioP/E ÷ EPS growth rate | — | 3.16x | 2.23x | 3.66x | — |
| EV / EBITDAEnterprise value multiple | 7.15x | 15.34x | 25.17x | 14.36x | 8.41x |
| Price / SalesMarket cap ÷ Revenue | 0.72x | 7.45x | 13.67x | 5.35x | 1.75x |
| Price / BookPrice ÷ Book value/share | 0.39x | 78.44x | — | 3.52x | — |
| Price / FCFMarket cap ÷ FCF | 4.87x | 19.20x | 27.65x | 19.84x | 6.62x |
Profitability & Efficiency
Evenly matched — MSCI and TRI each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
VRSK delivers a 4.4% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $-3 for CLVT. TRI carries lower financial leverage with a 0.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRSK's 16.26x. On the Piotroski fundamental quality scale (0–9), MSCI scores 8/9 vs VRSK's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.8% | +4.4% | — | +12.7% | — |
| ROA (TTM)Return on assets | -1.2% | +16.7% | +24.0% | +8.5% | +3.2% |
| ROICReturn on invested capital | +0.6% | +33.0% | +34.9% | +11.2% | +7.1% |
| ROCEReturn on capital employed | +0.7% | +39.6% | +44.3% | +13.6% | +7.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 8 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.92x | 16.26x | — | 0.18x | — |
| Net DebtTotal debt minus cash | $4.2B | $2.9B | $5.8B | $1.6B | $2.7B |
| Cash & Equiv.Liquid assets | $329M | $2.2B | $515M | $511M | $826M |
| Total DebtShort + long-term debt | $4.5B | $5.0B | $6.3B | $2.1B | $3.5B |
| Interest CoverageEBIT ÷ Interest expense | 0.47x | 7.87x | 7.67x | 18.32x | 0.84x |
Total Returns (Dividends Reinvested)
MSCI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MSCI five years ago would be worth $12,792 today (with dividends reinvested), compared to $995 for CLVT. Over the past 12 months, IHS leads with a +38.6% total return vs TRI's -50.0%. The 3-year compound annual growth rate (CAGR) favors MSCI at 8.7% vs CLVT's -28.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -14.1% | -20.7% | +4.5% | -26.8% | +12.0% |
| 1-Year ReturnPast 12 months | -33.4% | -43.0% | +7.8% | -50.0% | +38.6% |
| 3-Year ReturnCumulative with dividends | -63.2% | -14.5% | +28.6% | -18.2% | -10.9% |
| 5-Year ReturnCumulative with dividends | -90.0% | +1.8% | +27.9% | +5.7% | -51.6% |
| 10-Year ReturnCumulative with dividends | -71.0% | +137.1% | +720.9% | +155.3% | -51.6% |
| CAGR (3Y)Annualised 3-year return | -28.4% | -5.1% | +8.7% | -6.5% | -3.8% |
Risk & Volatility
Evenly matched — VRSK and MSCI each lead in 1 of 2 comparable metrics.
Risk & Volatility
VRSK is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than CLVT's 1.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MSCI currently trades 93.9% from its 52-week high vs TRI's 42.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.22x | -0.04x | 0.61x | 0.38x | 0.92x |
| 52-Week HighHighest price in past year | $4.77 | $322.92 | $626.28 | $221.97 | $8.95 |
| 52-Week LowLowest price in past year | $1.66 | $161.70 | $501.08 | $79.71 | $5.10 |
| % of 52W HighCurrent price vs 52-week peak | +58.3% | +54.1% | +93.9% | +42.1% | +92.0% |
| RSI (14)Momentum oscillator 0–100 | 58.7 | 39.5 | 54.6 | 48.2 | 47.7 |
| Avg Volume (50D)Average daily shares traded | 5.8M | 1.9M | 520K | 2.3M | 1.6M |
Analyst Outlook
Evenly matched — MSCI and TRI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CLVT as "Hold", VRSK as "Hold", MSCI as "Buy", TRI as "Buy", IHS as "Buy". Consensus price targets imply 57.5% upside for TRI (target: $147) vs 3.2% for IHS (target: $9). For income investors, TRI offers the higher dividend yield at 2.51% vs VRSK's 1.03%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $3.30 | $231.25 | $674.33 | $147.10 | $8.50 |
| # AnalystsCovering analysts | 20 | 25 | 27 | 27 | 21 |
| Dividend YieldAnnual dividend ÷ price | — | +1.0% | +1.2% | +2.5% | — |
| Dividend StreakConsecutive years of raises | 0 | 7 | 11 | 7 | — |
| Dividend / ShareAnnual DPS | — | $1.81 | $7.20 | $2.34 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +12.6% | +2.7% | +5.8% | +2.5% | 0.0% |
MSCI leads in 2 of 6 categories (Income & Cash Flow, Total Returns). CLVT leads in 1 (Valuation Metrics). 3 tied.
CLVT vs VRSK vs MSCI vs TRI vs IHS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CLVT or VRSK or MSCI or TRI or IHS a better buy right now?
For growth investors, MSCI Inc.
(MSCI) is the stronger pick with 9. 7% revenue growth year-over-year, versus -7. 6% for IHS Holding Limited (IHS). IHS Holding Limited (IHS) offers the better valuation at 19. 6x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate MSCI Inc. (MSCI) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CLVT or VRSK or MSCI or TRI or IHS?
On trailing P/E, IHS Holding Limited (IHS) is the cheapest at 19.
6x versus MSCI Inc. at 37. 8x. On forward P/E, Clarivate Plc is actually cheaper at 3. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: MSCI Inc. wins at 1. 77x versus Thomson Reuters Corporation's 2. 83x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — CLVT or VRSK or MSCI or TRI or IHS?
Over the past 5 years, MSCI Inc.
(MSCI) delivered a total return of +27. 9%, compared to -90. 0% for Clarivate Plc (CLVT). Over 10 years, the gap is even starker: MSCI returned +720. 9% versus CLVT's -71. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CLVT or VRSK or MSCI or TRI or IHS?
By beta (market sensitivity over 5 years), Verisk Analytics, Inc.
(VRSK) is the lower-risk stock at -0. 04β versus Clarivate Plc's 1. 22β — meaning CLVT is approximately -3506% more volatile than VRSK relative to the S&P 500. On balance sheet safety, Thomson Reuters Corporation (TRI) carries a lower debt/equity ratio of 18% versus 16% for Verisk Analytics, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CLVT or VRSK or MSCI or TRI or IHS?
By revenue growth (latest reported year), MSCI Inc.
(MSCI) is pulling ahead at 9. 7% versus -7. 6% for IHS Holding Limited (IHS). On earnings-per-share growth, the picture is similar: IHS Holding Limited grew EPS 108. 6% year-over-year, compared to -30. 5% for Thomson Reuters Corporation. Over a 3-year CAGR, VRSK leads at 7. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CLVT or VRSK or MSCI or TRI or IHS?
MSCI Inc.
(MSCI) is the more profitable company, earning 38. 4% net margin versus -8. 2% for Clarivate Plc — meaning it keeps 38. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSCI leads at 54. 7% versus 2. 9% for CLVT. At the gross margin level — before operating expenses — MSCI leads at 82. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CLVT or VRSK or MSCI or TRI or IHS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, MSCI Inc. (MSCI) is the more undervalued stock at a PEG of 1. 77x versus Thomson Reuters Corporation's 2. 83x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Clarivate Plc (CLVT) trades at 3. 8x forward P/E versus 30. 0x for MSCI Inc. — 26. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TRI: 57. 5% to $147. 10.
08Which pays a better dividend — CLVT or VRSK or MSCI or TRI or IHS?
In this comparison, TRI (2.
5% yield), MSCI (1. 2% yield), VRSK (1. 0% yield) pay a dividend. CLVT, IHS do not pay a meaningful dividend and should not be held primarily for income.
09Is CLVT or VRSK or MSCI or TRI or IHS better for a retirement portfolio?
For long-horizon retirement investors, Verisk Analytics, Inc.
(VRSK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 04), 1. 0% yield, +137. 1% 10Y return). Both have compounded well over 10 years (VRSK: +137. 1%, CLVT: -71. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CLVT and VRSK and MSCI and TRI and IHS?
These companies operate in different sectors (CLVT (Technology) and VRSK (Industrials) and MSCI (Financial Services) and TRI (Industrials) and IHS (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
VRSK, MSCI, TRI pay a dividend while CLVT, IHS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.